INTS Competitors & Alternatives
Compare Intensity Therapeutics, Inc. Common stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
INTS
Main Stock$5.22
Tradestie Score
51
Market Cap
$12.65M
Analyst Upside
+695.8%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$350.16
|
$160.70B | 24.9 | 62 | Compare |
|
GILD
Gilead Sciences Inc
|
$135.87
|
$137.92B | 20.3 | 60 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$834.45
|
$46.96B | 43.3 | 63 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$105.19
|
$24.57B | - | 60 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$183.34
|
$22.61B | 20.2 | 63 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$131.59
|
$13.59B | 28.5 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$43.61
|
$11.09B | 16.1 | 66 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$54.59
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$41.04
|
$10.04B | 20.2 | 63 | Compare |
|
TECH
Bio-Techne Corp.
|
$60.58
|
$9.33B | 111.8 | 54 | Compare |
More INTS Analysis
Data updated: Apr 21, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry